| 产品描述: | NSD-IN-3 (compound 3) is a potent nuclear receptor binding SET domain (NSD) inhibitor. NSD-IN-3 inhibits NSD2-SET and NSD3-SET with IC50 values of 0.81 μM and 0.84 μM, respectively. NSD-IN-3 inhibits histone H3K36 dimethylation and decreases the expression of NSDs-targeted genes in non-small cell lung cancer cells. NSD-IN-3 induces s-phase cell cycle arrest and apoptosis. |
| 体外研究: |
Guidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified according to your specific needs). 1. 4-Di-10-ASP (1 μM), DOPC (10 mM), and DOPG.html" class="link-product" target="_blank">DOPG (1 mM) is dissolved in methanol/chloroform (25 L, 1:2 v/v). 2. The solution is allowed to dry overnight under vacuum to obtain lamellar lipid films, which in turn are hydrated with the transcription/translation solution (25 L) for three hours at 37℃. 3. An aliquot (10 L) of the solution thus prepared is placed on a glass slide and sealed by a cover glass. 4. The sample is immediately observed with a confocal laser-scanning microscope, an argon laser (488 nm) is employed to excite the 4-Di-10-ASP. |
| 保存条件: |
2-8°C, 干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.616 ml |
8.081 ml |
16.162 ml |
| 5 mM |
0.323 ml |
1.616 ml |
3.232 ml |
| 10 mM |
0.162 ml |
0.808 ml |
1.616 ml |
| 50 mM |
0.032 ml |
0.162 ml |
0.323 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |